tiprankstipranks
Trending News
More News >
22nd Century (XXII)
NASDAQ:XXII
Advertisement

22nd Century (XXII) Price & Analysis

Compare
1,770 Followers

XXII Stock Chart & Stats


22nd Century News

XXII FAQ

What was 22nd Century’s price range in the past 12 months?
22nd Century lowest stock price was $1.87 and its highest was $1572.05 in the past 12 months.
    What is 22nd Century’s market cap?
    22nd Century’s market cap is $6.82M.
      When is 22nd Century’s upcoming earnings report date?
      22nd Century’s upcoming earnings report date is Nov 05, 2025 which is in 69 days.
        How were 22nd Century’s earnings last quarter?
        22nd Century released its earnings results on Aug 14, 2025. The company reported -$13.16 earnings per share for the quarter, missing the consensus estimate of -$6.21 by -$6.95.
          Is 22nd Century overvalued?
          According to Wall Street analysts 22nd Century’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does 22nd Century pay dividends?
            22nd Century does not currently pay dividends.
            What is 22nd Century’s EPS estimate?
            22nd Century’s EPS estimate is -0.73.
              How many shares outstanding does 22nd Century have?
              22nd Century has 3,513,872 shares outstanding.
                What happened to 22nd Century’s price movement after its last earnings report?
                22nd Century reported an EPS of -$13.16 in its last earnings report, missing expectations of -$6.21. Following the earnings report the stock price went down -10.112%.
                  Which hedge fund is a major shareholder of 22nd Century?
                  Among the largest hedge funds holding 22nd Century’s share is GMT Capital Corp. It holds 22nd Century’s shares valued at 0.

                    Company Description

                    22nd Century

                    22nd Century Group, Inc. (XXII) is a biotechnology company focused on the development of innovative solutions for the tobacco and hemp industries. The company specializes in genetic engineering and plant biotechnology, aiming to create low-nicotine tobacco products designed to reduce dependence on nicotine. Additionally, 22nd Century is involved in the production and commercialization of hemp-derived products, including cannabinoid extracts and related applications. The company operates primarily in the sectors of biotechnology, agriculture, and health.

                    22nd Century (XXII) Earnings & Revenues

                    XXII Earnings Call

                    Q2 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The company's strategic shift to high-margin products and the launch of VLN products are positive steps, but the delay in achieving profitability and potential cash flow issues present significant challenges.View all XXII earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Universal
                    Turning Point Brands
                    Greenlane Holdings
                    Kaival Brands Innovations Group
                    Ispire Technology, Inc.

                    Ownership Overview

                    40.21%0.02%6.60%53.17%
                    40.21% Insiders
                    6.60% Other Institutional Investors
                    53.17% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis